ArticleVaccines2020

Possible Cross-Reactivity between SARS-CoV-2 Proteins, CRM197 and Proteins in Pneumococcal Vaccines May Protect Against Symptomatic SARS-CoV-2 Disease and Death.

Robert Root-BernsteinPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.